See more : MetLife, Inc. (MET-PF) Income Statement Analysis – Financial Results
Complete financial analysis of Cann Global Limited (CGB.AX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Cann Global Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Aptitude Software Group plc (APTD.L) Income Statement Analysis – Financial Results
- PrimeCare Systems, Inc. (PCYS) Income Statement Analysis – Financial Results
- Eisai Co., Ltd. (4523.T) Income Statement Analysis – Financial Results
- NovAccess Global Inc. (XSNX) Income Statement Analysis – Financial Results
- Osmond Resources Limited (OSM.AX) Income Statement Analysis – Financial Results
Cann Global Limited (CGB.AX)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.canngloballimited.com
About Cann Global Limited
Cann Global Limited engages in the production and distribution of medicinal cannabis medications, natural foods, and cosmeceuticals in Australia and internationally. It operates through Hemp and Medical Cannabis Products, and Mining Exploration and Evaluation segments. The company grows and cultivates hemp and medical cannabis products; provides nutritious and vitamin packed plant-based foods under the Grass Roots brand; and offers skincare products under the Fuss Pot brand. It also engages in the exploration and development of bauxite. The company was formerly known as Queensland Bauxite Limited. Cann Global Limited was incorporated in 2007 and is based in Sydney, Australia.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 562.34K | 1.49M | 1.78M | 480.65K | 3.72M | 0.00 | 0.00 | 0.00 | 0.00 | 14.77K | 201.90K | 190.75K | 108.56K | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 640.53K | 1.16M | 1.31M | 562.22K | 202.85K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | -78.20K | 325.75K | 469.86K | -81.57K | 3.52M | 0.00 | 0.00 | 0.00 | 0.00 | 14.77K | 201.90K | 190.75K | 108.56K | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | -13.91% | 21.89% | 26.37% | -16.97% | 94.55% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% | 100.00% | 100.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 17.76K | 101.04K | 2.13M | 407.88K | 500.28K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 2.76M | 3.17M | 3.24M | 2.95M | 2.52M | 1.44M | 902.90K | 1.49M | 626.58K | 474.40K | 844.15K | 882.16K | 573.62K | 799.67K | 832.01K |
| Selling & Marketing | 0.00 | 292.21K | 442.19K | 207.32K | 226.42K | 212.32K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 95.07K | 10.55K | 48.24K | 7.09K |
| SG&A | 0.00 | 3.06M | 3.61M | 3.45M | 3.17M | 2.73M | 1.44M | 902.90K | 1.49M | 626.58K | 474.40K | 844.15K | 977.23K | 584.16K | 847.91K | 839.10K |
| Other Expenses | 0.00 | -1.87M | -595.75K | -368.75K | -2.93M | 2.29M | -156.58K | 12.34K | 25.00K | 1.33M | 900.32K | 2.19M | 4.06M | 803.17K | 747.58K | 492.42K |
| Operating Expenses | 0.00 | 4.25M | 4.06M | 6.27M | 5.36M | 5.52M | 1.82M | 1.23M | 2.58M | 1.98M | 1.37M | 4.26M | 5.03M | 1.39M | 1.60M | 1.33M |
| Cost & Expenses | 0.00 | 9.80K | 6.32K | 7.95K | 8.93K | 5.72M | 1.82M | 1.23M | 2.58M | 1.98M | 1.37M | 4.26M | 5.03M | 1.39M | 1.60M | 1.33M |
| Interest Income | 0.00 | 191.44K | 163.63K | 124.73K | 123.29K | 152.69K | 193.83K | 211.01K | 171.15K | 167.06K | 207.40K | 333.13K | 95.39K | 15.53K | 134.02K | 143.55K |
| Interest Expense | 0.00 | 34.59K | 99.52K | 2.01M | 911.62K | 447.21K | 73.69K | 219.20K | 24.09K | 586.21K | 433.00 | 5.78K | 1.49K | 2.06K | 926.00 | 3.69K |
| Depreciation & Amortization | 228.49K | 232.47K | 155.02K | 79.14K | 62.08K | 33.23K | 4.29K | 4.61K | 4.90K | 11.10K | 26.65K | 49.45K | 35.26K | 128.31K | 62.27K | 143.55K |
| EBITDA | 0.00 | -3.56M | -4.21M | -5.96M | -5.24M | -207.70K | -1.79M | -1.00M | -2.38M | -1.80M | -1.13M | -1.48M | -4.71M | -1.13M | -1.40M | -1.19M |
| EBITDA Ratio | 0.00% | -1,040.46% | -280.77% | -334.68% | -1,718.66% | -113.60% | 0.00% | 0.00% | 0.00% | 0.00% | -7,621.79% | -734.48% | -2,470.52% | -1,045.49% | 0.00% | 0.00% |
| Operating Income | 0.00 | -4.19K | -5.26K | -5.77K | -5.44K | -4.26M | -1.82M | -1.23M | -2.58M | -1.96M | -1.36M | -4.06M | -4.84M | -1.28M | -1.60M | -1.33M |
| Operating Income Ratio | 0.00% | -0.75% | -0.35% | -0.32% | -1.13% | -114.49% | 0.00% | 0.00% | 0.00% | 0.00% | -9,206.23% | -2,010.37% | -2,539.01% | -1,177.99% | 0.00% | 0.00% |
| Total Other Income/Expenses | 0.00 | -4.89M | -236.76K | -2.28M | -3.79M | -2.65M | -36.44K | 4.15K | 172.06K | -441.80K | -1.09M | 2.41M | 342.30K | 13.47K | 133.09K | 139.87K |
| Income Before Tax | 0.00 | -9.08M | -4.77M | -8.05M | -9.23M | -4.71M | -1.86M | -1.22M | -2.41M | -2.40M | -2.45M | -1.64M | -4.50M | -1.27M | -1.46M | -1.19M |
| Income Before Tax Ratio | 0.00% | -1,614.57% | -320.59% | -451.86% | -1,921.24% | -126.51% | 0.00% | 0.00% | 0.00% | 0.00% | -16,613.15% | -814.72% | -2,359.56% | -1,165.58% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | -2.77M | -815.68K | 1.60M | -4.89M | 292.67K | -82.89K | 231.54K | 49.09K | 563.56K | 433.00 | 2.20M | 1.49K | 15.53K | 134.02K | 0.00 |
| Net Income | 0.00 | -8.22M | -4.62M | -8.01M | -6.43M | -5.00M | -1.86M | -1.22M | -2.41M | -2.40M | -2.45M | -1.64M | -4.50M | -1.27M | -1.46M | -1.19M |
| Net Income Ratio | 0.00% | -1,461.39% | -310.57% | -449.68% | -1,338.81% | -134.37% | 0.00% | 0.00% | 0.00% | 0.00% | -16,613.15% | -814.72% | -2,359.56% | -1,165.58% | 0.00% | 0.00% |
| EPS | 0.00 | -0.03 | -0.02 | -0.06 | -0.10 | -0.08 | -0.04 | -0.04 | -0.11 | -0.20 | -0.22 | -0.15 | -0.56 | -0.48 | -0.58 | -0.61 |
| EPS Diluted | 0.00 | -0.03 | -0.02 | -0.06 | -0.10 | -0.08 | -0.04 | -0.04 | -0.11 | -0.20 | -0.22 | -0.15 | -0.56 | -0.48 | -0.58 | -0.61 |
| Weighted Avg Shares Out | 0.00 | 246.74M | 196.37M | 125.74M | 64.47M | 61.72M | 48.26M | 30.87M | 22.27M | 12.26M | 11.13M | 11.13M | 8.01M | 2.64M | 2.54M | 1.94M |
| Weighted Avg Shares Out (Dil) | 0.00 | 246.74M | 196.37M | 125.74M | 64.47M | 61.72M | 48.26M | 30.87M | 22.27M | 12.26M | 11.13M | 11.13M | 8.01M | 2.64M | 2.54M | 1.94M |
Source: https://incomestatements.info
Category: Stock Reports